olfactory mucosal cells	14
paw	46
function	59
regeneration of severed corticospinal tract fibres across the lesion	76
regeneration	76
severed corticospinal tract fibres across the lesion	92
severed corticospinal tract fibres	92
the lesion	134
Mie Yamamotoa , b , Geoffrey Raismana , , Daqing Lia , Ying Lia A B S T R A C T Previous studies from our laboratory reported that transplantation of a mixture of 50 % p75 + olfactory ensheathing cells -LRB- OECs -RRB- and fibroblasts derived from the outer layers of the adult olfactory bulb into unilateral lesions of the rat corticospinal tract -LRB- CST -RRB- restore function in a directed fore-paw retrieval task and induce regeneration of severed CST axons across the lesion	146
Mie Yamamotoa	146
b , Geoffrey Raismana ,	160
b	160
Geoffrey Raismana	163
Daqing Lia , Ying Lia A B S T R A C T Previous studies from our laboratory reported that transplantation of a mixture of 50 % p75 + olfactory ensheathing cells -LRB- OECs -RRB- and fibroblasts derived from the outer layers of the adult olfactory bulb into unilateral lesions of the rat corticospinal tract -LRB- CST -RRB- restore function in a directed fore-paw retrieval task and induce regeneration of severed CST axons across the lesion	184
Daqing Lia	184
Ying Lia	196
A B S T R A C T Previous studies	206
our laboratory	244
transplantation of a mixture of 50 % p75 + olfactory ensheathing cells -LRB- OECs -RRB- and fibroblasts derived from the outer layers of the adult olfactory bulb into unilateral lesions of the rat corticospinal tract -LRB- CST -RRB-	273
transplantation	273
a mixture of 50 % p75 + olfactory ensheathing cells -LRB- OECs -RRB- and fibroblasts derived from the outer layers of the adult olfactory bulb into unilateral lesions of the rat corticospinal tract -LRB- CST -RRB-	292
a mixture of 50 % p75 + olfactory ensheathing cells -LRB- OECs -RRB-	292
a mixture of 50 % p75	292
a mixture	292
50 % p75	305
olfactory ensheathing cells -LRB- OECs -RRB-	314
olfactory ensheathing cells	314
OECs	343
fibroblasts derived from the outer layers of the adult olfactory bulb into unilateral lesions of the rat corticospinal tract -LRB- CST -RRB-	353
fibroblasts	353
the outer layers of the adult olfactory bulb	378
the outer layers	378
the adult olfactory bulb	398
unilateral lesions of the rat corticospinal tract -LRB- CST -RRB-	428
unilateral lesions	428
the rat corticospinal tract -LRB- CST -RRB-	450
the rat corticospinal tract	450
CST	479
function in a directed fore-paw retrieval task	492
function	492
a directed fore-paw retrieval task	504
regeneration of severed CST axons	550
regeneration	550
severed CST axons	566
the lesion	591
future clinical application	607
it	635
reparative cells	668
an olfactory mucosal biopsy via intranasal endoscopy	690
an olfactory mucosal biopsy	690
intranasal endoscopy	722
the more invasive intracranial approach	765
an olfactory bulb	815
this purpose	839
we	853
our original CST lesion paradigm	861
mucosal OEC preparations	913
a similar repair	950
those from the bulb	970
those	970
the bulb	981
We	991
the case of bulbar OEC preparations	1012
the case	1012
bulbar OEC preparations	1024
the mucosal cells	1049
fore-paw retrieval	1090
there	1133
no evidence of any of the severed CST axons crossing the lesion site , suggesting that the recovery of function is due to some other reaction , such as sprouting of damaged or undamaged fibres	1143
no evidence	1143
any of the severed CST axons crossing the lesion site , suggesting that the recovery of function is due to some other reaction , such as sprouting of damaged or undamaged fibres	1158
any	1158
the severed CST axons crossing the lesion site , suggesting that the recovery of function is due to some other reaction , such as sprouting of damaged or undamaged fibres	1165
the severed CST axons	1165
the lesion site	1196
the recovery of function	1229
the recovery	1229
function	1245
some other reaction , such as sprouting of damaged or undamaged fibres	1264
some other reaction	1264
damaged or undamaged fibres	1306
the previous findings with bulbar cells	1349
the previous findings	1349
bulbar cells	1376
the mucosal cell cultures	1390
only 5 % of OECs and a conversely much larger proportion of fibroblasts	1426
only 5 % of OECs	1426
only 5 %	1426
OECs	1437
a conversely much larger proportion of fibroblasts	1446
a conversely much larger proportion	1446
fibroblasts	1485
These cell preparations	1498
minimal migratory ability	1529
complete bridges	1574
the lesions	1598
Introduction Many groups	1615
the use of olfactory ensheathing cells -LRB- OECs -RRB-	1653
the use	1653
olfactory ensheathing cells -LRB- OECs -RRB-	1664
olfactory ensheathing cells	1664
OECs	1693
repair of axon lesions	1702
repair	1702
axon lesions	1712
the CNS -LRB- Imaizumi et al. , 1998 ; Jeffery et al. , 2005 ; Li et al. , 1997 ; Lu et al. , 2002 ; Ramer et al. , 2004 ; Ramón-Cueto et al. , 1998 , 2000 ; Toft et al. , 2007 -RRB-	1728
the CNS	1728
Imaizumi et al. , 1998 ; Jeffery et al. , 2005 ; Li et al. , 1997 ; Lu et al. , 2002 ; Ramer et al. , 2004 ; Ramón-Cueto et al. , 1998 , 2000 ; Toft et al. , 2007	1737
Imaizumi	1737
et al. , 1998 ; Jeffery et al. , 2005 ; Li et al. , 1997 ; Lu et al. , 2002 ; Ramer et al. , 2004 ; Ramón-Cueto et al. , 1998 , 2000 ; Toft et al. , 2007	1746
et al. , 1998	1746
et al.	1746
1998	1754
Jeffery et al. , 2005	1760
Jeffery	1760
et al. , 2005	1768
et al.	1768
2005	1776
Li et al. , 1997	1782
Li	1782
et al. , 1997	1785
et al.	1785
1997	1793
Lu et al. , 2002	1799
Lu	1799
et al. , 2002	1802
et al.	1802
2002	1810
Ramer et al. , 2004	1816
Ramer	1816
et al. , 2004	1822
et al.	1822
2004	1830
Ramón-Cueto et al. , 1998 , 2000	1836
Ramón-Cueto	1836
et al. , 1998 , 2000	1848
et al.	1848
1998	1856
2000	1862
Toft et al. , 2007	1868
Toft	1868
et al. , 2007	1873
et al.	1873
2007	1881
previous studies	1891
we	1908
transplantation of a culture consisting of a roughly equal mixture of OECs and fibroblasts cultured from the outer layers of the olfactory bulb	1922
transplantation	1922
a culture consisting of a roughly equal mixture of OECs and fibroblasts cultured from the outer layers of the olfactory bulb	1941
a culture	1941
a roughly equal mixture of OECs and fibroblasts cultured from the outer layers of the olfactory bulb	1965
a roughly equal mixture	1965
OECs and fibroblasts	1992
the outer layers of the olfactory bulb	2027
the outer layers	2027
the olfactory bulb	2047
directed fore-paw	2086
-LRB- DFR -RRB- on the operated side	2113
-LRB- DFR -RRB-	2113
the operated side	2122
unilateral lesions of the upper cervical corticospinal tract -LRB- CST -RRB- -LRB- Keyvan-Fouladi et al. , 2003 ; Li et al. , 1997 -RRB-	2146
unilateral lesions	2146
the upper cervical corticospinal tract -LRB- CST -RRB- -LRB- Keyvan-Fouladi et al. , 2003 ; Li et al. , 1997 -RRB-	2168
the upper cervical corticospinal tract -LRB- CST -RRB-	2168
the upper cervical corticospinal tract	2168
CST	2208
Keyvan-Fouladi	2214
et al. , 2003 ; Li et al. , 1997	2229
et al.	2229
2003 ; Li et al.	2237
2003	2237
Li et al.	2243
Li	2243
et al.	2246
1997	2254
Histological examination	2261
corticospinal axons	2298
the graft	2342
grey matter caudal	2369
the lesion	2391
a view to developing amethod for application in clinical situations	2408
a view	2408
developing amethod for application in clinical situations	2418
developing amethod	2418
application in clinical situations	2441
application	2441
clinical situations	2456
it	2476
the necessity for craniotomy and bulbectomy	2519
the necessity	2519
craniotomy and bulbectomy	2537
autologous OECs for transplantation	2586
autologous OECs	2586
transplantation	2606
the less invasive intranasal approach	2625
the nasal mucosa -LRB- Choi et al. , 2008 ; Féron et al. , 2005 ; Lu et al. , 2002 ; Ramer et al. , 2004 ; Steward et al. , 2006 -RRB-	2666
the nasal mucosa	2666
Choi et al. , 2008 ; Féron et al. , 2005 ; Lu et al. , 2002 ; Ramer et al. , 2004 ; Steward et al. , 2006	2684
Choi	2684
et al. , 2008 ; Féron et al. , 2005 ; Lu et al. , 2002 ; Ramer et al. , 2004 ; Steward et al. , 2006	2689
et al. , 2008	2689
et al.	2689
2008	2697
Féron et al. , 2005	2703
Féron	2703
et al. , 2005	2709
et al.	2709
2005	2717
Lu et al. , 2002	2723
Lu	2723
et al. , 2002	2726
et al.	2726
2002	2734
Ramer et al. , 2004	2740
Ramer	2740
et al. , 2004	2746
et al.	2746
2004	2754
Steward et al. , 2006	2760
Steward	2760
et al. , 2006	2768
et al.	2768
2006	2776
Ongoing studies	2783
purified OECs of mucosal origin	2812
purified OECs	2812
mucosal origin	2829
many properties	2854
those of bulbar origin -LRB- Richter et al. , 2005 -RRB-	2875
those	2875
bulbar origin -LRB- Richter et al. , 2005 -RRB-	2884
bulbar origin	2884
Richter	2899
et al. , 2005	2907
et al.	2907
2005	2915
the present study	2925
we	2943
our original CST lesion/DFR paradigm	2951
mixed cell cultures derived from the olfactory mucosa	3004
mixed cell cultures	3004
the olfactory mucosa	3037
a similar repair	3070
those from the olfactory bulbs	3090
those	3090
the olfactory bulbs	3101
Results	3126
1 -- Individual directed reaching responses for the fore-paws of the operated side for the 6 rats which received transplants at 8 weeks after lesion	3139
1	3139
Individual directed reaching responses for the fore-paws of the operated side for the 6 rats which received transplants at 8 weeks after lesion	3143
Individual	3143
responses for the fore-paws of the operated side for the 6 rats which received transplants at 8 weeks after lesion	3172
responses	3172
the fore-paws of the operated side for the 6 rats which received transplants at 8 weeks after lesion	3186
the fore-paws	3186
the operated side for the 6 rats which received transplants at 8 weeks after lesion	3203
the operated side	3203
the 6 rats	3225
transplants	3251
8 weeks	3266
lesion	3280
A to E start to show recovery at 7 , 11 , 28 days after transplantation -LRB- T -RRB- .	3288
A to E start	3288
E	3293
start	3295
recovery	3309
7 , 11 ,	3321
7	3321
11	3324
28 days	3328
transplantation	3342
T	3359
F	3363
no recovery of function over the entire postoperative period of 10 weeks	3371
no recovery	3371
function over the entire postoperative period of 10 weeks	3386
function	3386
the entire postoperative period of 10 weeks	3400
the entire postoperative period	3400
10 weeks	3435
transplantation	3450
Eight injured , untransplanted controls -LRB- not shown in the figure -RRB-	3467
Eight injured	3467
Eight	3467
untransplanted controls -LRB- not shown in the figure -RRB-	3482
untransplanted controls	3482
the figure	3520
no recovery	3544
F. Ordinate , number of reaches of the fore-paw on the operated side for a total of 50 reaches by both sides ; abscissa , time in weeks after lesion ; T , time of transplant	3563
F. Ordinate	3563
number of reaches of the fore-paw on the operated side for a total of 50 reaches by both sides ; abscissa , time in weeks after lesion ; T , time of transplant	3576
number of reaches of the fore-paw on the operated side for a total of 50 reaches by both sides	3576
number	3576
reaches of the fore-paw on the operated side for a total of 50 reaches by both sides	3586
reaches	3586
the fore-paw on the operated side for a total of 50 reaches by both sides	3597
the fore-paw	3597
the operated side for a total of 50 reaches by both sides	3613
the operated side	3613
a total of 50 reaches by both sides	3635
a total	3635
50 reaches by both sides	3646
50 reaches	3646
both sides	3660
abscissa , time in weeks after lesion	3672
abscissa	3672
time in weeks after lesion	3682
time	3682
weeks after lesion	3690
weeks	3690
lesion	3702
T , time of transplant	3710
T	3710
time of transplant	3713
time	3713
transplant	3721
Fig. 2 -- Mean DFR scores -LRB- ± SD -RRB- for the 5 responding transplanted rats -LRB- top line , solid circles -RRB- and the 8 rats without transplants -LRB- lower line , open triangles -RRB- .	3734
Fig. 2	3734
Mean DFR scores -LRB- ± SD -RRB- for the 5 responding transplanted rats -LRB- top line , solid circles -RRB- and the 8 rats without transplants -LRB- lower line , open triangles -RRB-	3743
Mean DFR scores -LRB- ± SD -RRB-	3743
Mean DFR scores	3743
± SD	3760
the 5 responding transplanted rats -LRB- top line , solid circles -RRB- and the 8 rats without transplants -LRB- lower line , open triangles -RRB-	3769
the 5	3769
transplanted rats -LRB- top line , solid circles -RRB- and the 8 rats without transplants -LRB- lower line , open triangles -RRB-	3786
transplanted rats -LRB- top line , solid circles -RRB-	3786
transplanted rats	3786
top line , solid circles	3805
top line	3805
solid circles	3815
the 8 rats without transplants -LRB- lower line , open triangles -RRB-	3834
the 8 rats	3834
transplants -LRB- lower line , open triangles -RRB-	3853
transplants	3853
lower line , open triangles	3866
lower line	3866
open triangles	3878
The non-responding transplanted rat	3895
The mean score	3948
25 reaches	3974
lesion	3992
no rat	4019
a single instance of DFR	4033
a single instance	4033
DFR	4054
8 weeks	4062
the 10 weeks after transplantation	4076
the 10 weeks	4076
transplantation	4095
the mean for the 5 responding rats	4112
the mean	4112
the 5 responding rats	4125
a maximum of 22 ± 1.6	4172
number of reaches per trial of 50 ; abscissa time in weeks after lesion ; T , time of transplant	4202
number of reaches per trial of 50 ; abscissa time in weeks after lesion ; T , time	4202
number of reaches per trial of 50	4202
number	4202
reaches per trial of 50	4212
reaches	4212
trial of 50	4224
trial	4224
50	4233
abscissa time in weeks after lesion	4237
abscissa time	4237
weeks after lesion	4254
weeks	4254
lesion	4266
T , time	4274
T	4274
time	4277
transplant	4285
Fig. 3 -- -LRB- A -RRB- BD labelled CST fibres -LRB- red -RRB- abut directly on green fluorescent transplanted mucosal cells but do not enter the transplant .	4298
Fig. 3	4298
-LRB- A -RRB- BD labelled CST fibres -LRB- red -RRB- abut directly on green fluorescent transplanted mucosal cells but do not enter the transplant	4307
-LRB- A -RRB-	4307
BD	4311
CST fibres -LRB- red -RRB- abut directly	4323
CST fibres -LRB- red -RRB- abut	4323
CST fibres -LRB- red -RRB-	4323
CST fibres	4323
red	4335
green fluorescent transplanted mucosal cells	4357
the transplant	4419
-LRB- B -RRB- High power view of the interface between the CST fibres severed by the lesion and the transplanted cells at the region marked in A and B by the 2 white arrowheads .	4435
-LRB- B -RRB- High power	4435
B	4436
view of the interface between the CST fibres severed by the lesion and the transplanted cells at the region marked in A and B by the 2 white arrowheads	4450
view	4450
the interface between the CST fibres severed by the lesion and the transplanted cells at the region marked in A and B by the 2 white arrowheads	4458
the interface	4458
the CST fibres severed by the lesion and the transplanted cells at the region marked in A and B by the 2 white arrowheads	4480
the CST fibres	4480
the lesion and the transplanted cells at the region marked in A and B by the 2 white arrowheads	4506
the lesion	4506
the transplanted cells at the region marked in A and B by the 2 white arrowheads	4521
the transplanted cells	4521
the region marked in A and B by the 2 white arrowheads	4547
the region	4547
A and B by the 2 white arrowheads	4568
A and B	4568
the 2 white arrowheads	4579
-LRB- C -RRB- Lesion cavity	4603
-LRB- C -RRB-	4603
Lesion cavity	4607
scarred astrocytes -LRB- GFAP , red -RRB- with processes invading the cavity	4643
scarred astrocytes -LRB- GFAP , red -RRB-	4643
scarred astrocytes	4643
GFAP , red	4663
GFAP	4663
red	4669
processes invading the cavity	4679
processes	4679
the cavity	4698
macrophages -LRB- DAPI blue -RRB-	4731
macrophages	4731
DAPI blue	4744
The transplanted GFP labelled mucosal cells -LRB- green -RRB-	4756
The transplanted GFP labelled mucosal cells	4756
The transplanted GFP	4756
mucosal cells	4786
the host tissue in the edge of the lesion	4824
the host tissue	4824
the edge of the lesion	4843
the edge	4843
the lesion	4855
the lesions	4882
-LRB- D -RRB- High power view of the local interaction of host axons -LRB- neurofilament , red -RRB- , astrocytic processes -LRB- GFAP , blue -RRB- , and transplanted mucosal cells -LRB- GFP , green -RRB- .	4895
-LRB- D -RRB- High power	4895
D	4896
view of the local interaction of host axons -LRB- neurofilament , red -RRB- , astrocytic processes -LRB- GFAP , blue -RRB- , and transplanted mucosal cells -LRB- GFP , green -RRB-	4910
view	4910
the local interaction of host axons -LRB- neurofilament , red -RRB- , astrocytic processes -LRB- GFAP , blue -RRB- , and transplanted mucosal cells -LRB- GFP , green -RRB-	4918
the local interaction of host axons -LRB- neurofilament , red -RRB-	4918
the local interaction	4918
host axons -LRB- neurofilament , red -RRB-	4943
host axons	4943
neurofilament , red	4955
neurofilament	4955
red	4970
astrocytic processes -LRB- GFAP , blue -RRB-	4976
astrocytic processes	4976
GFAP , blue	4998
GFAP	4998
blue	5004
transplanted mucosal cells -LRB- GFP , green -RRB-	5015
transplanted mucosal cells	5015
GFP , green	5043
GFP	5043
green	5048
Rostral to the right .	5056
Rostral	5056
the right	5067
A , B , D sagittal sections , C , horizontal .	5078
A , B , D	5078
B	5080
sagittal sections , C , horizontal	5084
sagittal sections , C ,	5084
sagittal sections	5084
C	5103
Survival times : 8 weeks after lesion followed by 2 weeks -LRB- in A , B -RRB- and 4 weeks -LRB- in C , D -RRB- after transplantation .	5118
Survival times	5118
8 weeks after lesion followed by 2 weeks -LRB- in A , B -RRB- and 4 weeks -LRB- in C , D -RRB- after transplantation	5134
8 weeks	5134
lesion followed by 2 weeks -LRB- in A , B -RRB- and 4 weeks -LRB- in C , D -RRB- after transplantation	5148
lesion	5148
2 weeks -LRB- in A , B -RRB- and 4 weeks -LRB- in C , D -RRB-	5167
2 weeks -LRB- in A , B -RRB-	5167
in A , B	5176
in A	5176
B	5181
4 weeks -LRB- in C , D -RRB-	5188
C , D	5200
C	5200
D	5202
transplantation	5211
Scale bars , 200 μm -LRB- A , C -RRB- 100 μm -LRB- B -RRB- , 20 μm -LRB- D -RRB- .	5228
Scale bars	5228
200 μm -LRB- A , C -RRB- 100 μm -LRB- B -RRB-	5240
200 μm -LRB- A , C -RRB-	5240
A , C	5248
A	5248
C	5250
100 μm -LRB- B -RRB-	5253
B	5261
20 μm -LRB- D -RRB-	5265
D	5272
2.1	5277
Morphology and composition of cultured cells The cell cultures used for transplantation	5282
Morphology and composition	5282
cells	5321
The cell cultures used for transplantation	5327
The cell cultures	5327
transplantation	5354
amixture of cell types	5374
amixture	5374
cell types	5386
The majority	5398
fibroblast	5427
cells	5443
5 %	5457
p75-positive OECs -LRB- Li et al. , 2008 -RRB-	5465
p75-positive OECs	5465
Li	5484
et al. , 2008	5487
et al.	5487
2008	5495
the elongated spindle shaped OECs in bulbar cultures -LRB- Barnett et al. , 1993 ; Li et al. , 1998 ; Ramón-Cueto and Valverde , 1995 -RRB-	5509
the	5509
spindle shaped OECs	5523
bulbar cultures	5546
Barnett et al. , 1993 ; Li et al. , 1998 ; Ramón-Cueto and Valverde , 1995	5563
Barnett	5563
et al. , 1993 ; Li et al. , 1998 ; Ramón-Cueto and Valverde , 1995	5571
et al. , 1993	5571
et al.	5571
1993	5579
Li et al. , 1998	5585
Li	5585
et al. , 1998	5588
et al.	5588
1998	5596
Ramón-Cueto and Valverde , 1995	5602
Ramón-Cueto and Valverde	5602
1995	5628
the p75-positive cells in the mucosal cultures	5635
the p75-positive cells	5635
the mucosal cultures	5661
a flattened morphology , not obviously different from the larger , p75	5686
the larger	5739
negative presumptive fibroblast component of the cultures	5756
negative presumptive fibroblast component	5756
the cultures	5801
2.2	5815
Directed fore-paw reaching Beginning from 3 days after a unilateral lesion of the CST	5820
Directed fore-paw	5820
3 days after a unilateral lesion of the CST	5862
3 days	5862
a unilateral lesion of the CST	5875
a unilateral lesion	5875
the CST	5898
fore-paw	5916
DFR	5935
twice a week	5953
8 weeks	5970
Rats which recovered DFR spontaneously during this period	5979
Rats	5979
DFR	6000
this period	6025
the effect of transplants -LRB- Yamamoto et al. , 2009 -RRB-	6060
the effect	6060
transplants -LRB- Yamamoto et al. , 2009 -RRB-	6074
transplants	6074
Yamamoto	6087
et al. , 2009	6096
et al.	6096
2009	6104
The present series	6111
14 rats which had shown no recovery of DFR throughout the 8 weeks after lesion	6142
14 rats	6142
no recovery of DFR	6166
no recovery	6166
DFR	6181
the 8 weeks	6196
lesion	6214
these	6225
6 rats	6232
transplants	6248
6 rats	6261
no further intervention	6272
2	6300
injection of culture medium	6306
injection	6306
culture medium	6319
the site of the lesion	6339
the site	6339
the lesion	6351
DFR testing	6363
a further 10 weeks	6393
transplants of mucosal cell cultures	6429
transplants	6429
mucosal cell cultures	6444
5 of the 6 rats	6467
5	6467
the 6 rats	6472
DFR on the operated side	6491
DFR	6491
the operated side	6498
1 week -LRB- n = 1 -RRB- , 2 weeks -LRB- n = 2 -RRB- or 4 weeks -LRB- n = 2 -RRB-	6526
1 week -LRB- n = 1 -RRB-	6526
1 week	6526
n	6534
1	6536
2 weeks -LRB- n = 2 -RRB-	6540
n	6549
2	6551
4 weeks -LRB- n = 2 -RRB-	6557
n	6566
2	6568
most tests	6575
the recovered paw	6586
over 50 % of the pre-operative level	6615
over 50 %	6615
the pre-operative level	6627
that paw -LRB- Figs. 1 , 2 -RRB-	6655
that paw	6655
Figs. 1	6665
2	6674
One transplanted rat failed completely to show any DFR on the operated side .	6678
One	6678
transplanted rat	6682
any DFR on the operated side	6725
any DFR	6725
the operated side	6736
The 8 rats without transplants	6755
The 8 rats	6755
transplants	6774
no DFR	6793
any time	6803
the entire testing period	6817
2.3	6844
Histology The lesions	6849
1-2 mm in diameter centred at the C1/C2 levels	6876
1-2 mm	6876
diameter	6886
the C1/C2 levels	6906
the CST , the adjacent grey matter of Rexed 's laminae V to VII and the ascending dorsal columns to the pial surface -LRB- Yamamoto et al. , 2009 -RRB-	6933
the CST	6933
the adjacent grey matter of Rexed 's laminae V to VII and the ascending dorsal columns to the pial surface -LRB- Yamamoto et al. , 2009 -RRB-	6942
the adjacent grey matter	6942
Rexed 's laminae V to VII and the ascending dorsal columns to the pial surface -LRB- Yamamoto et al. , 2009 -RRB-	6970
Rexed 's laminae V	6970
Rexed 's	6970
VII and the ascending dorsal columns to the pial surface	6991
VII and the	6991
dorsal columns	7013
the pial surface	7031
Yamamoto	7049
et al. , 2009	7058
et al.	7058
2009	7066
transplanted rats	7076
groups of donor cells identified by the fluorescence of the lentivirally transduced GFP -LRB- green fluorescent protein -RRB- label -LRB- Figs. 3A , B -RRB-	7094
groups	7094
donor cells identified by the fluorescence of the lentivirally transduced GFP -LRB- green fluorescent protein -RRB- label -LRB- Figs. 3A , B -RRB-	7104
donor cells	7104
the fluorescence of the lentivirally transduced GFP -LRB- green fluorescent protein -RRB- label -LRB- Figs. 3A , B -RRB-	7130
the fluorescence	7130
the lentivirally transduced GFP -LRB- green fluorescent protein -RRB- label -LRB- Figs. 3A , B -RRB-	7150
the lentivirally transduced GFP -LRB- green fluorescent protein -RRB- label	7150
GFP -LRB- green fluorescent protein -RRB-	7178
GFP	7178
green fluorescent protein	7183
Figs. 3A , B	7217
Figs. 3A	7217
B	7227
contact	7251
adjacent host spinal cord tissue	7264
the ventral edge of the injection track -LRB- Fig. 3C -RRB-	7300
the ventral edge	7300
the injection track -LRB- Fig. 3C -RRB-	7320
the injection track	7320
Fig. 3C	7341
these areas	7354
the transplanted cells	7366
ensheathed host axons	7411
the adjacent spinal cord tissue -LRB- Fig. 3D -RRB-	7436
the adjacent spinal cord tissue	7436
Fig. 3D	7469
The transplanted cells	7479
the lesion centre	7521
no case	7546
a continuous tissue bridge across the lesion	7561
a continuous tissue bridge	7561
the lesion	7595
the CST	7609
The cells	7618
minimal tendency	7635
They	7664
the lesion track	7709
a very minor extent along the rostrocaudal axis	7738
a very minor extent	7738
the rostrocaudal axis	7764
the lesion site	7789
the single rat	7809
which	7824
DFR the transplanted cells lay deep in the spinal cord , medial to the ventral horn and distant from the CST and the grey matter of laminae V to VII	7847
DFR	7847
the transplanted cells	7851
the spinal cord	7886
the ventral horn and distant	7913
the ventral horn	7913
distant	7934
the CST	7947
the grey matter of laminae V	7959
the grey matter	7959
laminae V	7978
VII	7991
2.4	7996
CST axons The immunofluorescence study	8001
CST axons	8001
The immunofluorescence study	8011
substantial numbers of neurofilament immunoreactive fibres	8052
substantial numbers	8052
neurofilament immunoreactive fibres	8075
the dorsal CST rostral	8127
the lesion	8153
no case	8168
we	8180
any of these fibres	8193
any	8193
these fibres	8200
the transplants	8233
This	8250
sampling	8272
the numbers of BD labelled axons in sections of the dorsal CST at 1-2 mm rostral and caudal to the lesion	8281
the numbers	8281
BD labelled axons in sections of the dorsal CST at 1-2 mm rostral and caudal to the lesion	8296
BD	8296
axons in sections of the dorsal CST	8308
axons	8308
sections of the dorsal CST	8317
sections	8317
the dorsal CST	8329
1-2 mm rostral and caudal	8347
1-2 mm rostral	8347
caudal	8366
the lesion	8376
These rough estimates	8388
a mean of 443 ± 48 -LRB- SD , n = 6 -RRB-	8418
a mean	8418
443 ± 48 -LRB- SD , n = 6 -RRB-	8428
443 ± 48	8428
SD , n = 6	8436
SD	8436
n = 6	8440
n	8440
6	8442
axons rostral to the lesion	8445
axons rostral	8445
the lesion	8462
every case	8477
the axons	8488
the rostral border of the lesions	8509
the rostral border	8509
the lesions	8531
no case were labelled fibres found in the CST caudal to the lesion -LRB- Figs. 3A , B -RRB-	8550
no case	8550
fibres found in the CST caudal to the lesion -LRB- Figs. 3A , B -RRB-	8572
fibres	8572
the CST caudal	8588
the lesion -LRB- Figs. 3A , B -RRB-	8606
the lesion	8606
Figs. 3A , B	8618
Figs. 3A	8618
B	8628
the edges of the lesion	8639
the edges	8639
the lesion	8652
some axons	8663
GFP	8693
fluorescent transplanted cells -LRB- Fig. 3D -RRB- in the one-to-one fashion typical of OECs in other transplant situations -LRB- e.g. -LRB- Ibrahim et al. , 2009 -RRB-	8697
fluorescent transplanted cells	8697
Fig. 3D	8729
the one-to-one fashion typical of OECs in other transplant situations -LRB- e.g. -LRB- Ibrahim et al. , 2009 -RRB-	8741
the one-to-one fashion	8741
OECs in other transplant situations -LRB- e.g. -LRB- Ibrahim et al. , 2009 -RRB-	8775
OECs	8775
other transplant situations -LRB- e.g. -LRB- Ibrahim et al. , 2009 -RRB-	8783
other transplant situations	8783
e.g.	8812
Ibrahim	8818
et al. , 2009	8826
et al.	8826
2009	8834
Discussion The present study	8846
Discussion	8846
The present study	8857
14 rats which had complete abolition of DFR for 8 weeks after lesion	8887
14 rats	8887
complete abolition of DFR for 8 weeks	8905
complete abolition	8905
DFR for 8 weeks	8927
DFR	8927
8 weeks	8935
lesion	8949
these	8960
6 rats	8967
transplants of olfactory mucosal cell cultures	8983
transplants	8983
olfactory mucosal cell cultures	8998
the 8 week point	9033
5 of them	9055
5	9055
them	9060
recovery of DFR	9072
recovery	9072
DFR	9084
between 1 and 4 weeks	9088
transplantation	9116
The 8	9133
rats which did not receive transplants	9148
rats	9148
transplants	9175
no recovery	9194
up to 18 weeks	9210
the lesion	9231
We	9243
it	9270
the transplantation of the olfactory mucosal cell cultures which was responsible for the recovery of DFR	9277
the transplantation	9277
the olfactory mucosal cell cultures which was responsible for the recovery of DFR	9300
the olfactory mucosal cell cultures	9300
the recovery of DFR	9362
the recovery	9362
DFR	9378
The histology	9383
transplanted cells	9418
they	9447
continuous bridges	9465
the CST lesions	9491
neurofilament immunohistochemistry	9513
there	9548
no indication of any regenerating CST fibres entering or traversing the transplants	9558
no indication	9558
any regenerating CST fibres	9575
the transplants	9626
this	9646
orthograde tracing of BD injected into the cortex	9668
orthograde	9668
BD injected into the cortex	9690
BD	9690
the cortex	9707
These results	9719
our former series	9745
injections of bulbar OEC/fibroblast mixtures	9769
injections	9769
bulbar OEC/fibroblast mixtures	9783
larger transplants which filled the lesion sites and provided bridges allowing severed CST axons to enter and cross the transplants	9821
larger transplants	9821
the lesion sites	9853
bridges allowing severed CST axons to enter and cross the transplants	9883
bridges	9883
CST axons	9908
the transplants	9937
arborisations in the grey matter -LRB- Keyvan-Fouladi et al. , 2003 ; Li et al. , 1997 -RRB-	9981
arborisations	9981
the grey matter -LRB- Keyvan-Fouladi et al. , 2003 ; Li et al. , 1997 -RRB-	9998
the grey matter	9998
Keyvan-Fouladi	10015
et al. , 2003 ; Li et al. , 1997	10030
et al.	10030
2003 ; Li et al.	10038
2003	10038
Li et al.	10044
Li	10044
et al.	10047
1997	10055
The fact that the transplantation of olfactory mucosal cell cultures mediate recovery of DFR in the absence of detectable regeneration by the severed CST axons across the lesion/transplant site	10062
The fact	10062
the transplantation of olfactory mucosal cell cultures	10076
the transplantation	10076
olfactory mucosal cell cultures	10099
recovery of DFR in the absence of detectable regeneration	10139
recovery	10139
DFR in the absence of detectable regeneration	10151
DFR	10151
the absence of detectable regeneration	10158
the absence	10158
detectable regeneration	10173
the severed CST axons across the lesion/transplant site	10200
the severed CST axons	10200
the lesion/transplant site	10229
this situation	10274
the recovery	10289
a different interaction of the transplanted cells with the host spinal tissue	10313
a different interaction	10313
the transplanted cells with the host spinal tissue	10340
the transplanted cells	10340
the host spinal tissue	10368
More detailed functional tests	10392
the extent to which the regeneration of severed axons after bulbar OEC transplants seen in our previous studies contributed to the observed functional recovery	10452
the extent	10452
the regeneration of severed axons after bulbar OEC transplants seen in our previous studies	10472
the regeneration	10472
severed axons after bulbar OEC transplants seen in our previous studies	10492
severed axons	10492
bulbar OEC transplants seen in our previous studies	10512
bulbar OEC transplants	10512
our previous studies	10543
the observed functional recovery	10579
Recovery of function in the absence of regeneration of the originally cut fibres	10613
Recovery	10613
function in the absence of regeneration of the originally cut fibres	10625
function	10625
the absence of regeneration of the originally cut fibres	10637
the absence	10637
regeneration of the originally cut fibres	10652
regeneration	10652
the originally cut fibres	10668
the originally cut	10668
fibres	10687
a number of other situations -LRB- Lu et al. , 2002 ; Toft et al. , 2007 -RRB-	10715
a number	10715
other situations -LRB- Lu et al. , 2002 ; Toft et al. , 2007 -RRB-	10727
other situations	10727
Lu	10745
et al. , 2002 ; Toft et al. , 2007	10748
et al.	10748
2002 ; Toft et al.	10756
2002	10756
Toft et al.	10762
Toft	10762
et al.	10767
2007	10775
Possible mechanisms for these effects	10782
Possible mechanisms	10782
these effects	10806
induction of sprouting	10834
induction	10834
the severed CST fibres above the lesion or the spared CST fibres in other regions -LRB- Anderson et al. , 2005 ; Bareyre et al. , 2004 ; Brus-Ramer et al. , 2007 ; Girgis et al. , 2007 ; Maier et al. , 2008 ; Weidner et al. , 2001 -RRB- , some alternative pathway involvement -LRB- Anderson et al. , 2007 ; Kanagal and Muir , 2009 -RRB- , diffusion of growth factors , or vascularisation -LRB- Ramer et al. , 2004 ; Vavrek et al. , 2006 -RRB-	10872
the severed CST fibres above the lesion or the spared CST fibres in other regions -LRB- Anderson et al. , 2005 ; Bareyre et al. , 2004 ; Brus-Ramer et al. , 2007 ; Girgis et al. , 2007 ; Maier et al. , 2008 ; Weidner et al. , 2001 -RRB-	10872
the severed CST fibres	10872
the lesion or the spared CST fibres in other regions -LRB- Anderson et al. , 2005 ; Bareyre et al. , 2004 ; Brus-Ramer et al. , 2007 ; Girgis et al. , 2007 ; Maier et al. , 2008 ; Weidner et al. , 2001 -RRB-	10901
the lesion	10901
the spared CST fibres in other regions -LRB- Anderson et al. , 2005 ; Bareyre et al. , 2004 ; Brus-Ramer et al. , 2007 ; Girgis et al. , 2007 ; Maier et al. , 2008 ; Weidner et al. , 2001 -RRB-	10915
the spared CST fibres	10915
other regions -LRB- Anderson et al. , 2005 ; Bareyre et al. , 2004 ; Brus-Ramer et al. , 2007 ; Girgis et al. , 2007 ; Maier et al. , 2008 ; Weidner et al. , 2001 -RRB-	10940
other regions	10940
Anderson et al. , 2005 ; Bareyre et al. , 2004 ; Brus-Ramer et al. , 2007 ; Girgis et al. , 2007 ; Maier et al. , 2008 ; Weidner et al. , 2001	10955
Anderson	10955
et al. , 2005 ; Bareyre et al. , 2004 ; Brus-Ramer et al. , 2007 ; Girgis et al. , 2007 ; Maier et al. , 2008 ; Weidner et al. , 2001	10964
et al. , 2005	10964
et al.	10964
2005	10972
Bareyre et al. , 2004	10978
Bareyre	10978
et al. , 2004	10986
et al.	10986
2004	10994
Brus-Ramer et al. , 2007	11000
Brus-Ramer	11000
et al. , 2007	11011
et al.	11011
2007	11019
Girgis et al. , 2007	11025
Girgis	11025
et al. , 2007	11032
et al.	11032
2007	11040
Maier et al. , 2008	11046
Maier	11046
et al. , 2008	11052
et al.	11052
2008	11060
Weidner et al. , 2001	11066
Weidner	11066
et al. , 2001	11074
et al.	11074
2001	11082
some alternative pathway involvement -LRB- Anderson et al. , 2007 ; Kanagal and Muir , 2009 -RRB-	11089
some alternative pathway involvement	11089
Anderson	11127
et al. , 2007 ; Kanagal and Muir , 2009	11136
et al.	11136
2007 ; Kanagal and Muir	11144
2007	11144
Kanagal and Muir	11150
2009	11168
diffusion of growth factors	11175
diffusion	11175
growth factors	11188
vascularisation -LRB- Ramer et al. , 2004 ; Vavrek et al. , 2006 -RRB-	11207
vascularisation	11207
Ramer	11224
et al. , 2004 ; Vavrek et al. , 2006	11230
et al.	11230
2004 ; Vavrek et al.	11238
2004	11238
Vavrek et al.	11244
Vavrek	11244
et al.	11251
2006	11259
Richter et al -LRB- Richter et al. , 2005 -RRB-	11266
Richter et al	11266
Richter	11266
et al	11274
Richter	11281
et al. , 2005	11289
et al.	11289
2005	11297
significant differences	11309
OEC-containing cultures	11341
the olfactory mucosa and those of bulbar origin	11370
the olfactory mucosa	11370
those of bulbar origin	11395
those	11395
bulbar origin	11404
Steward et al. , 2006	11429
Steward	11429
et al.	11437
2006	11445
our present study transplants of mucosal cell cultures differed clearly from the transplants of bulbar cell cultures	11456
our present study transplants	11456
mucosal cell cultures differed clearly from the transplants of bulbar cell cultures	11489
mucosal cell cultures	11489
the transplants of bulbar cell cultures	11533
the transplants	11533
bulbar cell cultures	11552
we	11573
our previous studies	11584
The cultures of cells from mucosal tissues	11606
The cultures	11606
cells from mucosal tissues	11622
cells	11622
mucosal tissues	11633
a preponderance of fibroblasts and only around 5 % of p75 - positive OECs -LRB- Li et al. , 2008 -RRB-	11662
a preponderance of fibroblasts	11662
a preponderance	11662
fibroblasts	11681
only around 5 % of p75 - positive OECs -LRB- Li et al. , 2008 -RRB-	11697
only around 5 % of p75	11697
only around 5 %	11697
p75	11715
positive OECs -LRB- Li et al. , 2008 -RRB-	11720
positive OECs	11720
Li	11735
et al. , 2008	11738
et al.	11738
2008	11746
Those from bulbar tissues cultured under similar conditions for the same time	11753
Those	11753
bulbar tissues cultured under similar conditions for the same time	11764
bulbar tissues	11764
similar conditions for the same time	11794
similar conditions	11794
the same time	11817
a 50/50 proportion of olfactory nerve fibroblasts and OECs -LRB- Deumens et al. , 2006 ; Li et al. , 1998 -RRB-	11843
a 50/50 proportion	11843
olfactory nerve fibroblasts and OECs -LRB- Deumens et al. , 2006 ; Li et al. , 1998 -RRB-	11865
olfactory nerve fibroblasts and OECs	11865
Deumens et al. , 2006 ; Li et al. , 1998	11903
Deumens	11903
et al. , 2006 ; Li et al. , 1998	11911
et al. , 2006	11911
et al.	11911
2006	11919
Li et al. , 1998	11925
Li	11925
et al. , 1998	11928
et al.	11928
1998	11936
transplantation	11949
the striking differences between these cell preparations in terms of their ability to fill lesions and mediate axon regeneration	11966
the striking differences	11966
these cell preparations in terms of their ability to fill lesions and mediate axon regeneration	11999
these cell preparations	11999
terms of their ability to fill lesions and mediate axon regeneration	12026
terms	12026
their ability to fill lesions and mediate axon regeneration	12035
lesions	12057
axon regeneration	12077
the different proportions or properties of the non-OECs within the cultured cell mixtures -LRB- Lakatos et al. , 2003 -RRB-	12107
the different proportions or properties	12107
the non-OECs within the cultured cell mixtures -LRB- Lakatos et al. , 2003 -RRB-	12150
the non-OECs within the cultured cell mixtures	12150
the cultured	12170
the	12170
Lakatos	12198
et al. , 2003	12206
et al.	12206
2003	12214
The possibility	12221
there	12254
an intrinsic difference between the OECs cultured from the mucosal samples and those from the outer layers of the olfactory bulb -- i.e. the olfactory nerve and glomerular layers	12267
an intrinsic difference	12267
the OECs cultured from the mucosal samples and those from the outer layers of the olfactory bulb -- i.e. the olfactory nerve and glomerular layers	12299
the OECs	12299
the mucosal samples and those from the outer layers of the olfactory bulb -- i.e. the olfactory nerve and glomerular layers	12322
the mucosal samples	12322
those from the outer layers of the olfactory bulb	12346
those	12346
the outer layers of the olfactory bulb	12357
the outer layers	12357
the olfactory bulb	12377
i.e. the olfactory nerve	12398
i.e.	12398
the olfactory nerve	12403
glomerular layers	12427
the bulbar cell cultures	12449
the fibroblastic component	12474
the meningeal coverings of the CNS	12535
the meningeal coverings	12535
the CNS	12562
the mucosal cultures	12574
the fibroblasts	12596
the lamina propria	12634
different properties from meningeal fibroblasts	12678
different properties	12678
meningeal fibroblasts	12704
we	12736
any other components of the mucosal cultures	12759
any other components	12759
the mucosal cultures	12783
the primary tissue	12805
a number of non-fibroblastic cell types derived from the glandular tissue and ducts of the lamina propria	12850
a number	12850
non-fibroblastic cell types derived from the glandular tissue and ducts of the lamina propria	12862
non-fibroblastic cell types	12862
the glandular tissue and ducts of the lamina propria	12903
the glandular tissue	12903
ducts of the lamina propria	12928
ducts	12928
the lamina propria	12937
It	12957
the case	12968
we	12982
any indication of the relative proportion of OECs	12997
any indication	12997
the relative proportion of OECs	13015
the relative proportion	13015
OECs	13042
the GFP fluorescent mixture of cells	13058
the GFP fluorescent mixture	13058
cells	13089
transplantation	13101
their course from the olfactory mucosa to the olfactory bulb	13139
their course	13139
the olfactory mucosa to the olfactory bulb	13157
the olfactory mucosa	13157
the olfactory bulb	13181
the OECs	13201
a tight investment round	13215
the olfactory axons	13240
their outer surface	13277
a continuous basal lamina facing a collagen containing extracellular space with an outer sheath of very narrow fibroblastic processes	13300
a continuous basal lamina	13300
a collagen	13333
extracellular space	13355
an outer sheath of very narrow fibroblastic processes	13380
an outer sheath	13380
very narrow fibroblastic processes	13399
they	13440
the olfactory bulb	13451
this arrangement changes dramatically	13470
this arrangement changes	13470
The fibroblast	13509
the meningeal coverings of the CNS	13569
the meningeal coverings	13569
the CNS	13596
the OECs	13609
fibroblasts	13637
they	13650
a basal lamina	13667
they	13687
direct contact and interleave	13697
astrocytes , thus ` opening the door ' into the CNS	13732
astrocytes , thus	13732
astrocytes	13732
the door	13758
the CNS	13773
These differences between the bulbar OECs and those from the earlier part of the course of the olfactory nerves	13782
These differences	13782
the bulbar OECs and those from the earlier part of the course of the olfactory nerves	13808
the bulbar OECs	13808
those from the earlier part of the course of the olfactory nerves	13828
those	13828
the earlier part of the course of the olfactory nerves	13839
the earlier part	13839
the course of the olfactory nerves	13859
the course	13859
the olfactory nerves	13873
cell	13901
they	13921
the different cells with which the OECs are in contact with fibroblasts in the nerve , astrocytes in the bulb	13944
the different cells	13944
the OECs	13975
contact	13991
fibroblasts in the nerve	14004
fibroblasts	14004
the nerve	14019
astrocytes in the bulb	14030
astrocytes	14030
the bulb	14044
what extent these differences underlie the different types of cells obtained in culture , and , more to the present point , to what extent they underlie the different reparative properties of the two cultures after transplantation	14057
what extent	14057
these differences	14069
the different types of cells obtained in culture , and , more to the present point , to what extent they underlie the different reparative properties of the two cultures after transplantation	14096
the different types	14096
cells obtained in culture , and , more to the present point , to what extent they underlie the different reparative properties of the two cultures after transplantation	14119
cells	14119
culture	14137
the present point , to what extent they underlie the different reparative properties of the two cultures after transplantation	14159
the present point	14159
they	14193
the different reparative properties of the two cultures	14207
the different reparative properties	14207
the two cultures	14246
transplantation	14269
an important subject for future investigation	14293
an important subject	14293
future investigation	14318
we	14342
the remarkable properties of OECs and their promise of repair of CNS lesions	14363
the remarkable properties of OECs	14363
the remarkable properties	14363
OECs	14392
their promise of repair of CNS lesions	14401
their promise	14401
repair of CNS lesions	14418
repair	14418
CNS lesions	14428
Experimental procedures 4.1 .	14445
Experimental procedures	14445
4.1	14469
Cell culture Mucosal cells	14474
the method previously described -LRB- Li et al. , 2008 -RRB-	14528
the method previously described	14528
the method	14528
Li	14561
et al. , 2008	14564
et al.	14564
2008	14572
adult -LRB- body weight , 200-230 g -RRB- female rats	14588
body weight , 200-230 g	14595
body weight	14595
200-230 g	14608
locally inbred Albino Swiss -LRB- AS -RRB- strain	14634
locally inbred	14634
AS	14663
terminal anaesthesia and the nasal septum exposed	14697
terminal anaesthesia	14697
the nasal septum exposed	14722
the nasal septum	14722
The olfactory mucosa identified by its unique amber colour	14748
The olfactory mucosa	14748
its unique amber colour	14783
ice-cold Hanks '	14828
Hanks '	14837
balanced salt solution -LRB- HBSS -RRB- without calcium and magnesium	14845
balanced salt solution -LRB- HBSS -RRB-	14845
balanced salt solution	14845
HBSS	14869
calcium and magnesium	14883
1 % penicillin	14923
streptomycin -LRB- Invitrogen , Paisley , UK -RRB-	14937
streptomycin	14937
Invitrogen	14951
Paisley	14963
UK	14972
HBSS	14993
excessive mucus	15008
1 ml of dispase II -LRB- 2.4 units/ml , in Puck 's solution ; Roche Diagnostics GmbH , Mannheim , Germany -RRB-	15047
1 ml	15047
dispase II -LRB- 2.4 units/ml , in Puck 's solution ; Roche Diagnostics GmbH , Mannheim , Germany -RRB-	15055
dispase II	15055
2.4 units/ml , in Puck 's solution ; Roche Diagnostics GmbH , Mannheim , Germany	15067
2.4 units/ml	15067
Puck 's solution ; Roche Diagnostics GmbH	15084
Puck 's solution	15084
Puck 's	15084
Roche Diagnostics GmbH	15101
Mannheim , Germany	15125
37 °C for 45 min	15147
37 °C	15147
45 min	15156
The enzymatic reaction	15164
the tissue	15215
HBSS	15229
The lamina propria	15235
small pieces	15272
a McIlwain tissue chopper -LRB- Campden , Loughborough , UK -RRB- collected into 2 ml of 0.25 % collagenase type I -LRB- Sigma -- Aldrich Company Ltd. , Gillingham , UK -RRB- in a Dulbecco 's - modified Eagle medium -LRB- DMEM -RRB- / Ham 's F-12 with GlutaMAX ™ 1.0 mg/ml insulin , 0.67 mg/ml transferrin and 0.55 mg/ml selenium , 1 % penicillin -- streptomycin and 10 % deactivated fetal calf serum -LRB- FCS ; all from Invitrogen -RRB- , and incubated at 37 °C for 5 min	15292
a McIlwain tissue chopper	15292
Campden	15319
Loughborough	15328
UK	15342
2 ml of 0.25 % collagenase type I -LRB- Sigma -- Aldrich Company Ltd. , Gillingham , UK -RRB-	15361
2 ml	15361
0.25 % collagenase type I -LRB- Sigma -- Aldrich Company Ltd. , Gillingham , UK -RRB-	15369
0.25 % collagenase type	15369
I -LRB- Sigma -- Aldrich Company Ltd. , Gillingham , UK -RRB-	15392
I	15392
Sigma	15395
Aldrich Company Ltd. , Gillingham , UK	15401
Aldrich Company Ltd.	15401
Gillingham , UK	15423
a Dulbecco 's	15442
Eagle medium -LRB- DMEM -RRB- / Ham 's F-12 with GlutaMAX ™ 1.0 mg/ml insulin , 0.67 mg/ml transferrin and 0.55 mg/ml selenium , 1 % penicillin -- streptomycin and 10 % deactivated fetal calf serum -LRB- FCS ; all from Invitrogen -RRB-	15464
Eagle medium -LRB- DMEM -RRB- / Ham 's F-12 with GlutaMAX ™ 1.0 mg/ml insulin , 0.67 mg/ml transferrin and 0.55 mg/ml selenium , 1 % penicillin -- streptomycin	15464
Eagle medium -LRB- DMEM -RRB- / Ham 's F-12 with GlutaMAX ™ 1.0 mg/ml insulin , 0.67 mg/ml transferrin and 0.55 mg/ml selenium , 1 % penicillin --	15464
Eagle medium -LRB- DMEM -RRB-	15464
Eagle medium	15464
DMEM	15478
Ham 's F-12 with GlutaMAX ™ 1.0 mg/ml insulin , 0.67 mg/ml transferrin and 0.55 mg/ml selenium , 1 % penicillin	15484
Ham 's F-12	15484
Ham 's	15484
GlutaMAX ™ 1.0 mg/ml insulin , 0.67 mg/ml transferrin and 0.55 mg/ml selenium , 1 % penicillin	15500
GlutaMAX ™ 1.0 mg/ml insulin	15500
GlutaMAX	15500
™ 1.0 mg/ml insulin	15508
0.67 mg/ml transferrin	15529
0.55 mg/ml selenium , 1 % penicillin	15556
streptomycin	15592
10 % deactivated fetal calf serum -LRB- FCS ; all from Invitrogen -RRB-	15609
10 %	15609
fetal calf serum -LRB- FCS ; all from Invitrogen -RRB-	15625
fetal calf serum	15625
FCS ; all from Invitrogen	15643
FCS	15643
all from Invitrogen	15648
all	15648
Invitrogen	15657
37 °C for 5 min	15687
37 °C	15687
5 min	15697
The pieces	15704
the collagenase reaction	15735
8 ml of HBSS	15782
8 ml	15782
HBSS	15789
300 × g for 5 min	15817
300 × g	15817
5 min	15827
the supernatant	15848
the tissue pellet	15865
further triturated to a cell suspension in a DMEM/F12 medium	15887
further	15887
a cell suspension in a DMEM/F12 medium	15909
a cell suspension	15909
a DMEM/F12 medium	15930
The resulting cells	15949
a density of 20 -- 25,000 cm − 2	15984
a density of 20	15984
a density	15984
20	15997
25,000 cm − 2	16000
25,000 cm −	16000
2	16010
35 mm culture dishes coated with poly-l-lysine -LRB- 0.1 mg/ml ; Sigma -- Aldrich -RRB- the medium replaced every 3 days	16015
35 mm culture dishes	16015
poly-l-lysine -LRB- 0.1 mg/ml ; Sigma -- Aldrich -RRB- the medium replaced every 3 days	16048
poly-l-lysine -LRB- 0.1 mg/ml ; Sigma -- Aldrich -RRB-	16048
poly-l-lysine	16048
0.1 mg/ml	16063
Sigma -- Aldrich	16074
Sigma	16074
Aldrich	16080
the medium	16089
every 3 days	16109
day 12	16126
the cells	16133
a lentiviral construct harbouring a GFP gene -LRB- Cavalieri et al. , 2003 ; Naldini et al. , 1996 ; Ruitenberg et al. , 2002 -RRB-	16165
a lentiviral construct	16165
a GFP gene -LRB- Cavalieri et al. , 2003 ; Naldini et al. , 1996 ; Ruitenberg et al. , 2002 -RRB-	16199
a GFP gene	16199
Cavalieri et al. , 2003 ; Naldini et al. , 1996 ; Ruitenberg et al. , 2002	16211
Cavalieri	16211
et al. , 2003 ; Naldini et al. , 1996 ; Ruitenberg et al. , 2002	16221
et al. , 2003	16221
et al.	16221
2003	16229
Naldini et al. , 1996	16235
Naldini	16235
et al. , 1996	16243
et al.	16243
1996	16251
Ruitenberg et al. , 2002	16257
Ruitenberg	16257
et al. , 2002	16268
et al.	16268
2002	16276
a further 2 days in culture	16289
a further 2 days	16289
culture	16309
the cells	16318
a cell suspension	16344
a concentration of 20-25	16374
a concentration	16374
20-25	16393
× 106 ml −	16398
1 in DMEM-F12	16406
1	16406
DMEM-F12	16411
FCS	16428
ice	16444
surgery time	16455
4.2	16469
Training Directed fore-paw reaching -LRB- DFR -RRB-	16474
Training Directed fore-paw reaching	16474
Training Directed fore-paw	16474
DFR	16511
as previously described -LRB- Keyvan-Fouladi et al. , 2003 ; Yamamoto et al. , 2009 -RRB-	16532
as previously described	16532
as previously	16532
Keyvan-Fouladi	16557
et al. , 2003 ; Yamamoto et al. , 2009	16572
et al.	16572
2003 ; Yamamoto et al.	16580
2003	16580
Yamamoto et al.	16586
Yamamoto	16586
et al.	16595
2009	16603
3 successive days before operation	16622
3 successive days	16622
operation	16647
the adult	16658
body weight , 180-200 g	16669
body weight	16669
180-200 g	16682
female inbred Albino Swiss strain rats	16693
a testing cage with a perspex front	16751
a testing cage	16751
a perspex front	16771
a vertical slit through which the rat can use the fore-paw to retrieve 3-5 mm fragments of noodles placed on a platform 5 cm above the floor level	16792
a vertical slit	16792
the rat	16822
the fore-paw to retrieve 3-5 mm fragments of noodles placed on a platform 5 cm above the floor level	16838
3-5 mm fragments of noodles placed on a platform 5 cm above the floor level	16863
3-5 mm fragments	16863
noodles placed on a platform 5 cm above the floor level	16883
noodles	16883
a platform 5 cm above the floor level	16901
a platform 5 cm	16901
the floor level	16923
Rats	16940
this action , without any need for food deprivation , and the number of times the right	16959
this action	16959
any need for food deprivation , and the number of times	16980
any need for food deprivation	16980
any need	16980
food deprivation	16993
the number of times	17015
the number	17015
times	17029
the right	17035
paws	17054
successful retrieval	17073
an overall total of 50 retrievals	17111
an overall total	17111
50 retrievals	17131
the present study	17150
we	17168
rats which used both right and left paws with an asymmetry of no greater than 15/35 during 50 reaches through the slit in the cage front	17180
rats	17180
both right	17196
paws	17216
an asymmetry of no greater than 15/35	17226
an asymmetry	17226
no greater than 15/35	17242
50 reaches	17271
the slit in the cage front	17290
the slit	17290
the cage front	17302
4.3	17318
Surgery Unilateral CST lesions	17323
a stainless steel electrode as previously reported -LRB- Yamamoto et al. , 2009 -RRB-	17370
a stainless steel electrode as previously reported	17370
a stainless steel electrode	17370
Yamamoto	17422
et al. , 2009	17431
et al.	17431
2009	17439
Avertin -LRB- 2,2,2-tribromoethanol , Sigma-Aldrich , Gillingham , UK -RRB- general anaesthesia	17452
Avertin -LRB- 2,2,2-tribromoethanol , Sigma-Aldrich , Gillingham , UK -RRB-	17452
Avertin	17452
2,2,2-tribromoethanol	17461
Sigma-Aldrich	17484
Gillingham , UK	17499
general anaesthesia	17515
the spinal cord	17536
the first and second cervical vertebrae	17572
A stainless steel electrode -LRB- A-M Systems , Carlsborg -RRB- of 250 μm diameter , insulated to within 1mmof the tip ,	17613
A stainless steel electrode -LRB- A-M Systems , Carlsborg -RRB-	17613
A stainless steel electrode	17613
A-M Systems	17642
Carlsborg	17655
250 μm diameter	17669
1mmof the tip	17706
1mmof	17706
the tip	17712
a point 0.3	17737
0.5 mm lateral to the midline to a depth of 1 mm below the surface of the spinal cord on the side preferred for retrievals during the pre-training period	17750
0.5 mm lateral	17750
the midline	17768
a depth of 1 mm	17783
a depth	17783
1 mm	17794
the surface of the spinal cord on the side preferred for retrievals during the pre-training period	17805
the surface	17805
the spinal cord on the side preferred for retrievals during the pre-training period	17820
the spinal cord	17820
the side preferred for retrievals during the pre-training period	17839
the side	17839
retrievals	17862
the pre-training period	17880
The CST and adjacent grey matter	17905
The CST	17905
adjacent grey matter	17917
a heat lesion produced by a radiofrequency lesion device -LRB- RFG-3C RF ; Radionics Inc. , Burlington , MA -RRB- operating at 10V for 1 min	17956
a heat lesion	17956
a radiofrequency lesion device -LRB- RFG-3C RF ; Radionics Inc. , Burlington , MA -RRB- operating	17982
RFG-3C RF ; Radionics Inc. , Burlington , MA	18014
RFG-3C RF	18014
Radionics Inc. , Burlington , MA	18025
10V for 1 min	18070
10V	18070
1 min	18078
All animal procedures	18085
accordance with UK Scientific Procedures -LRB- Animals -RRB- Acts	18127
UK Scientific Procedures	18143
Animals	18169
Three days	18184
surgery	18201
rats	18210
DFR function 3 times per week	18231
DFR function	18231
3 times	18244
week	18256
4.4	18262
Cell transplantation Six rats which had shown complete absence of DFR on the operated side for 8 weeks ,	18267
Cell transplantation Six rats	18267
Cell transplantation	18267
Six rats	18288
complete absence of DFR	18313
complete absence	18313
DFR	18333
the operated side for 8 weeks	18340
the operated side	18340
8 weeks	18362
transplants of 4-5 μl containing a total of around 100,000 syngeneic cultured mucosal cells	18380
transplants	18380
4-5 μl containing a total of around 100,000 syngeneic cultured mucosal cells	18395
4-5 μl	18395
a total of around 100,000 syngeneic cultured mucosal cells	18413
a total	18413
around 100,000 syngeneic cultured mucosal cells	18424
around 100,000 syngeneic	18424
mucosal cells	18458
it	18476
the original dorsal surface of spinal cord	18505
the original dorsal surface	18505
spinal cord	18536
the secondary operation	18551
the cell suspension	18576
a glass micropipette	18622
three different positions along a track passing through the lesion site at 2 , 1 , and 0.5 mm from the surface of spinal cord	18646
three different positions	18646
a track passing through the lesion site at 2 , 1 , and 0.5 mm from the surface of spinal cord	18678
a track	18678
the lesion site at 2 , 1 , and 0.5 mm	18702
the lesion site	18702
2 , 1 , and 0.5 mm	18721
2	18721
1	18724
0.5 mm	18731
the surface of spinal cord	18743
the surface	18743
spinal cord	18758
Two further rats which had shown no recovery of DFR on the operated side	18771
Two further rats	18771
no recovery of DFR	18804
no recovery	18804
DFR	18819
the operated side	18826
an injection of serum-free culture medium along the same	18853
an injection	18853
serum-free culture medium along the same	18869
serum-free culture medium	18869
the same	18901
The rats	18923
DFR function 3 days	18948
DFR function	18948
3 days	18961
the operation , 3 times a week	18974
the operation	18974
3 times a week	18989
3 times	18989
a week	18997
a further 10 weeks	19008
The rats	19028
deep general anaesthesia	19057
the end of 18 weeks	19085
the end	19085
18 weeks	19096
4.5	19106
Histology	19111
the presence of the transplanted mucosal OECs	19137
the presence	19137
the transplanted mucosal OECs	19153
regeneration of the severed CST axons	19194
regeneration	19194
the severed CST axons	19210
a further group of 6 rats with similar lesions	19233
a further group	19233
6 rats with similar lesions	19252
6 rats	19252
similar lesions	19264
transplants of mucosal OECs 8 weeks	19289
transplants	19289
mucosal OECs 8 weeks	19304
mucosal OECs	19304
8 weeks	19317
lesion	19331
a further 2 -- 6 weeks	19367
a further 2	19367
2	19377
6 weeks	19381
anaesthesia	19396
the rats	19408
a stereotaxic apparatus	19433
a craniotomy	19470
a 100 μm tip glass micropipette	19483
4 μl of 10 % biotinylated dextran amine -LRB- BD - 10,000 , lysine fixable , D1956 , Invitrogen , UK -RRB- in saline at each of 4 points along the mediolateral extent of the sensorimotor cortex on the side contralateral to the side of the spinal lesion -LRB- Li et al. , 1998 -RRB-	19534
4 μl	19534
10 % biotinylated dextran amine -LRB- BD - 10,000 , lysine fixable , D1956 , Invitrogen , UK -RRB- in saline at each of 4 points along the mediolateral extent of the sensorimotor cortex on the side contralateral to the side of the spinal lesion -LRB- Li et al. , 1998 -RRB-	19542
10 %	19542
dextran amine	19560
dextran	19560
- 10,000 , lysine fixable , D1956 , Invitrogen , UK -RRB- in saline	19577
- 10,000 , lysine fixable , D1956 , Invitrogen , UK -RRB-	19577
- 10,000 , lysine fixable , D1956 , Invitrogen	19577
10,000 , lysine fixable	19579
10,000	19579
lysine fixable	19587
D1956 , Invitrogen	19603
D1956	19603
Invitrogen	19610
UK	19622
saline	19629
each of 4 points along the mediolateral extent of the sensorimotor cortex	19639
each	19639
4 points along the mediolateral extent of the sensorimotor cortex	19647
4 points	19647
the mediolateral extent of the sensorimotor cortex	19662
the mediolateral extent	19662
the sensorimotor cortex	19689
the side contralateral	19716
the side of the spinal lesion -LRB- Li et al. , 1998 -RRB-	19742
the side	19742
the spinal lesion -LRB- Li et al. , 1998 -RRB-	19754
the spinal lesion	19754
Li	19773
et al. , 1998	19776
et al.	19776
1998	19784
2 weeks	19797
the rats	19806
4 % paraformaldehyde	19834
terminal anaesthesia	19860
The dissected spinal cord	19882
the same fixative overnight	19920
4 °C	19951
10 %	19977
20 % sucrose for at least 24 hr	19986
20 % sucrose	19986
at least 24 hr	20002
25 μm cryostat sections	20018
MAS-coated slides -LRB- Matsunami , Kyoto , Japan -RRB-	20063
MAS-coated slides	20063
Matsunami	20082
Kyoto	20093
Japan	20100
0.1 % PBS-milk triton followed by incubation with rabbit anti-heavy chain neurofilament -LRB- AHP245 , 1:500 AbD Serotec , Kidlington , UK -RRB- and mouse anti-GFAP -LRB- G3893 1:400 Sigma-Aldrich , Dorset , UK -RRB- as primary antibodies in 0.1 % PBS-triton overnight at 4 °C	20125
0.1 % PBS-milk triton	20125
incubation	20158
rabbit anti-heavy chain neurofilament -LRB- AHP245 , 1:500 AbD Serotec , Kidlington , UK -RRB- and mouse anti-GFAP -LRB- G3893 1:400 Sigma-Aldrich , Dorset , UK -RRB- as primary antibodies in 0.1 % PBS-triton overnight at 4 °C	20174
rabbit anti-heavy chain neurofilament -LRB- AHP245 , 1:500 AbD Serotec , Kidlington , UK -RRB-	20174
rabbit	20174
anti-heavy chain neurofilament -LRB- AHP245 , 1:500 AbD Serotec , Kidlington , UK -RRB-	20181
anti-heavy chain neurofilament	20181
AHP245 , 1:500 AbD Serotec , Kidlington , UK	20213
AHP245	20213
1:500 AbD Serotec	20221
Kidlington	20240
UK	20252
mouse anti-GFAP -LRB- G3893 1:400 Sigma-Aldrich , Dorset , UK -RRB- as primary antibodies in 0.1 % PBS-triton overnight at 4 °C	20260
mouse anti-GFAP -LRB- G3893 1:400 Sigma-Aldrich , Dorset , UK -RRB- as primary antibodies in 0.1 % PBS-triton overnight	20260
mouse anti-GFAP -LRB- G3893 1:400 Sigma-Aldrich , Dorset , UK -RRB- as primary antibodies in 0.1 % PBS-triton	20260
mouse anti-GFAP -LRB- G3893 1:400 Sigma-Aldrich , Dorset , UK -RRB-	20260
mouse anti-GFAP	20260
G3893 1:400 Sigma-Aldrich , Dorset , UK	20277
G3893 1:400 Sigma-Aldrich	20277
Dorset , UK	20304
primary antibodies in 0.1 % PBS-triton	20319
primary antibodies	20319
0.1 % PBS-triton	20341
4 °C	20370
The sections	20376
PBS	20404
Alexa fluor	20434
546	20446
633-conjugated goat anti-rabbit IgG or antimouse IgG -LRB- 1:400 Invitrogen , Paisley , UK -RRB- secondary antibody	20455
633-conjugated goat anti-rabbit IgG	20455
633-conjugated goat	20455
anti-rabbit IgG	20475
antimouse IgG -LRB- 1:400 Invitrogen , Paisley , UK -RRB- secondary antibody	20494
antimouse IgG	20494
1:400 Invitrogen , Paisley , UK	20509
1:400 Invitrogen , Paisley	20509
UK	20536
secondary antibody	20540
2 hr	20563
room temperature and counter stained with DAPI -LRB- D-21490 , 300nM Invitrogen , Paisley , UK -RRB-	20571
room temperature and counter	20571
DAPI -LRB- D-21490 , 300nM Invitrogen , Paisley , UK -RRB-	20613
DAPI	20613
D-21490	20619
300nM Invitrogen	20628
Paisley , UK	20646
BD labelling	20673
sections	20687
either Alexa fluor 546 - or 633-conjugates	20716
either Alexa fluor 546 -	20716
Alexa fluor	20723
546	20735
633-conjugates	20743
streptavidin -LRB- S21375 1:400 , Invitrogen , Paisley , UK -RRB- overnight at 4 °C	20761
streptavidin -LRB- S21375 1:400 , Invitrogen , Paisley , UK -RRB-	20761
streptavidin	20761
S21375 1:400	20775
Invitrogen	20789
Paisley , UK	20801
overnight at 4 °C	20814
overnight	20814
4 °C	20827
Sections	20833
DAPI	20867
Fluorescent images	20873
a TCS SP Leica confocal microscope or an LSM 510 META Zeiss confocal microscope	20912
a TCS SP Leica confocal microscope	20912
a TCS SP Leica	20912
confocal microscope	20927
an LSM 510 META Zeiss confocal microscope	20950
an LSM 510 META Zeiss	20950
confocal microscope	20972
Fluorescence microscopy	20993
a rough semi-quantitative estimate of the numbers of BD labelled axons in the dorsal CST by counts in single coronal sections or in longitudinal sections	21036
a rough semi-quantitative estimate	21036
the numbers of BD labelled axons in the dorsal CST by counts in single coronal sections or in longitudinal sections	21074
the numbers	21074
BD labelled axons in the dorsal CST by counts in single coronal sections or in longitudinal sections	21089
BD	21089
axons in the dorsal CST	21101
axons	21101
the dorsal CST	21110
counts in single coronal sections	21128
counts	21128
single coronal sections	21138
longitudinal sections	21168
each longitudinal section	21195
all axons	21222
an imaginary line	21263
a level approximately 1-2 mm rostral and caudal to the lesion	21291
a level approximately 1-2 mm rostral	21291
a level	21291
approximately 1-2 mm rostral	21299
caudal to the lesion	21332
caudal	21332
the lesion	21342
